scholarly journals Economic evaluations of big data analytics for clinical decision-making: a scoping review

2020 ◽  
Vol 27 (9) ◽  
pp. 1466-1475
Author(s):  
Lytske Bakker ◽  
Jos Aarts ◽  
Carin Uyl-de Groot ◽  
William Redekop

Abstract Objective Much has been invested in big data analytics to improve health and reduce costs. However, it is unknown whether these investments have achieved the desired goals. We performed a scoping review to determine the health and economic impact of big data analytics for clinical decision-making. Materials and Methods We searched Medline, Embase, Web of Science and the National Health Services Economic Evaluations Database for relevant articles. We included peer-reviewed papers that report the health economic impact of analytics that assist clinical decision-making. We extracted the economic methods and estimated impact and also assessed the quality of the methods used. In addition, we estimated how many studies assessed “big data analytics” based on a broad definition of this term. Results The search yielded 12 133 papers but only 71 studies fulfilled all eligibility criteria. Only a few papers were full economic evaluations; many were performed during development. Papers frequently reported savings for healthcare payers but only 20% also included costs of analytics. Twenty studies examined “big data analytics” and only 7 reported both cost-savings and better outcomes. Discussion The promised potential of big data is not yet reflected in the literature, partly since only a few full and properly performed economic evaluations have been published. This and the lack of a clear definition of “big data” limit policy makers and healthcare professionals from determining which big data initiatives are worth implementing.

Author(s):  
Fatma Chiheb ◽  
Fatima Boumahdi ◽  
Hafida Bouarfa

Big Data is an important topic for discussion and research. It has gained this importance due to the meaningful value that could be extracted from these data. The application of Big Data in the modern business allows enterprises to take faster and smarter decisions, achieving a real competitive advantage. However, a lot of Big Data projects provide disappointing results that don't address the decision-makers' needs due to many reasons. The main reason for this failure can be summarized in neglecting the study of the decision-making aspect of these projects. In light of this challenge, this study proposes the integration of decision aspect into Big Data as a solution. Therefore, this article presents three main contributions: 1) Clarify the definition of Big Data; 2) Presents BD-Da model, a conceptual model describes the levels that should be considered to develop a Big Data project aiming to solve a problem that calls a decision; 3) Describes a particular, logical, requirements-like approach that explains how a company develops a Big Data analytics project to support decision-making.


2021 ◽  
Vol 10 (4) ◽  
pp. 766 ◽  
Author(s):  
Ljiljana Trtica Majnarić ◽  
František Babič ◽  
Shane O’Sullivan ◽  
Andreas Holzinger

Multimorbidity refers to the coexistence of two or more chronic diseases in one person. Therefore, patients with multimorbidity have multiple and special care needs. However, in practice it is difficult to meet these needs because the organizational processes of current healthcare systems tend to be tailored to a single disease. To improve clinical decision making and patient care in multimorbidity, a radical change in the problem-solving approach to medical research and treatment is needed. In addition to the traditional reductionist approach, we propose interactive research supported by artificial intelligence (AI) and advanced big data analytics. Such research approach, when applied to data routinely collected in healthcare settings, provides an integrated platform for research tasks related to multimorbidity. This may include, for example, prediction, correlation, and classification problems based on multiple interaction factors. However, to realize the idea of this paradigm shift in multimorbidity research, the optimization, standardization, and most importantly, the integration of electronic health data into a common national and international research infrastructure is needed. Ultimately, there is a need for the integration and implementation of efficient AI approaches, particularly deep learning, into clinical routine directly within the workflows of the medical professionals.


2020 ◽  
Vol 98 ◽  
pp. 68-78 ◽  
Author(s):  
Aseem Kinra ◽  
Samaneh Beheshti-Kashi ◽  
Rasmus Buch ◽  
Thomas Alexander Sick Nielsen ◽  
Francisco Pereira

Author(s):  
Andrea Darrel ◽  
Margee Hume ◽  
Timothy Hardie ◽  
Jeffery Soar

The benefits of big data analytics in the healthcare sector are assumed to be substantial, and early proponents have been very enthusiastic (Chen, Chiang, & Storey, 2012), but little research has been carried out to confirm just what those benefits are, and to whom they accrue (Bollier, 2010). This chapter presents an overview of existing literature that demonstrates quantifiable, measurable benefits of big data analytics, confirmed by researchers across a variety of healthcare disciplines. The chapter examines aspects of clinical operations in healthcare including Cost Effectiveness Research (CER), Clinical Decision Support Systems (CDS), Remote Patient Monitoring (RPM), Personalized Medicine (PM), as well as several public health initiatives. This examination is in the context of searching for the benefits described resulting from the deployment of big data analytics. Results indicate the principle benefits are delivered in terms of improved outcomes for patients and lower costs for healthcare providers.


Sign in / Sign up

Export Citation Format

Share Document